Market Cap | 97.30M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -14.28M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -17.00% |
Sales | 1.29M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -36.00% |
Dividend | N/A | Price/Book | 1.44 | EPS next 5Y | - | 52W High Chg | -75.00% |
Recommedations | - | Quick Ratio | 37.02 | Shares Outstanding | 201.07M | 52W Low Chg | 4.00% |
Insider Own | 5.53% | ROA | -22.00% | Shares Float | 191.61M | Beta | - |
Inst Own | 3.13% | ROE | -38.62% | Shares Shorted/Prior | -/- | Price | 0.48 |
Gross Margin | -20.90% | Profit Margin | - | Avg. Volume | 247,578 | Target Price | - |
Oper. Margin | -1,084.05% | Earnings Date | Dec 9 | Volume | 532,570 | Change | -3.63% |
Numinus Wellness Inc. provides solutions to develop and deliver psychedelic-assisted psychotherapy and transform the mental health landscape. The company operates in two divisions, Salvation Botanicals and Numinus Health. The Salvation Botanicals division offers laboratory services, such as cultivation, analytical testing, product research and development, and ancillary services in the area of psychedelics; and full suite testing and custom testing of cannabis. The Numinus Health division provides supportive therapies and technologies to heal, connect, and grow with a focus on treating mental health and substance abuse; and services for psychotherapy, counselling, neurofeedback, physiotherapy, and other therapies. This division also offers training, facilities, and other operational resources to practitioners. The company is headquartered in Vancouver, Canada.